Metsera (MTSR) is down -15.0%, or -$12.50 to $70.68.
Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on MTSR:
- Viking Therapeutics Stock (VKTX) Jumps on Obesity Drug. The Next Big Pharma Target?
- Video: Health insurers weighed on by shutdown news, Trump post
- Morning Movers: Monday.com sinks following third quarter results
- Metsera Amends Merger Agreement with Pfizer
- Novo continues to look for opportunities in obesity, diabetes, Bloomberg says